Viewing Study NCT04055493


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-01-02 @ 1:12 AM
Study NCT ID: NCT04055493
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-26
First Post: 2019-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC
Sponsor: West German Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module